Beat Schillig

World-class Startups. Swiss Made.

📍 Switzerland, Switzerland🔄 Updated September 2026💼 17 investments📅 25 years investing🗓 Last invested Dec 2019
VC🌍 Switzerland
17
Total investments
8
Early stage
6
Mid stage
1
Late stage
25y
Years active

Portfolio

16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member & Angel Investor
Dec 2019
Exeon is a leading Swiss cyber security company, dedicated to protecting enterprise IT environments through AI-driven security analytics. The award-winning algorithms behind our flagship product ExeonTrace are based on over ten years of academic research at ETH Zürich and have been proven, expanded, and refined in global enterprise protection ever since. Exeon was awarded as one of Switzerland’s top three high-tech companies and consists of an interdisciplinary team of data scientists, machine learning experts, white hat hackers, network security specialists and business professionals. Our future-proof Network Detection and Response (NDR) software ExeonTrace allows security teams to monitor all network operations, immediately detect cyberthreats, and effectively secure their digital assets. As ExeonTrace relies on Metadata Analysis, its algorithms require no hardware sensors, are unaffected by encryption, and can be setup within a single day.
Board Member & Angel Investor
Feb 2019
greenteg provides high precision sensors for thermal sensing. Our sensors are integrated into OEM products and applied in R&D settings. All our products are fully developed and manufactured in Switzerland. 👉 Contact us to discuss your application at info@greenteg.com greenTEG AG was founded in 2009 as a spin-off of the Swiss Federal Institute of Technology (ETH). The company develops, manufactures, and markets thermal sensors for heat flux measurements in various applications and provides consulting on the thermal integration of its products. Today, greenTEG supplies OEMs as well as scientists in corporate and university labs around the world with its unique products. In 2020 greenTEG has launched CORE, the first wearable to measure continuously and non-invasively your core body temperature, clinical grade-wise. To discover more: 👉 www.greenTEG.com
Angel Investor
Oct 2018
1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention and management of disease and empowers people to live better lives. 1DROP highly values collaboration, prioritizing the needs of customers and rapidly delivering solutions. 1DROP’s innovative diagnostic solutions for multiplexed assays of proteins, nucleic acids and peptides serve as tools for the development of new therapies and drugs, disease research, and clinical diagnostic tests. The company is based in Neuchatel, Switzerland and Boston, United States and is supported by some of the most highly regarded experts in the field of biosensors.
Board Member & Angel Investor
Jun 2018
Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems’ main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise.
Angel Investor
Jul 2017
Synple Chem is changing the way in which chemical synthesis is done by providing a new automated synthesis technology that uses revolutionary, smart reagent capsules to make the synthesis of molecules faster and more efficient. Using this technology researchers in chemistry are able to accelerate their research and advance their programs in a fraction of the time. Our product addresses many of the limitations of chemical synthesis by enabling researchers with even basic chemistry expertise to rapidly synthesize organic compounds, in a fully automated manner that obviates the need to weigh and measure all but one of the reaction components; avoiding the use of excess reagents; eliminating tedious reaction workups; and ultimately freeing up the user to do more, faster!
Angel Investor
Feb 2016
We support companies who would like to do content marketing, but dont have the time or budget to create all the content necessary to stay top of mind. With our content curation suite – a software as a service solution – we let you discover current and relevant articles, comment them and then distribute them on the channels of your choice: your newsletter, website, social media channels or intranet.
Angel Investor
Apr 2015
L.E.S.S. designs and manufactures thinner, brighter, more uniform technical lighting systems. Thanks to our innovative approach, our aim is to deliver our customer with lighting systems that provide both intense and uniform light within a small form factor.
Angel Investor
Nov 2014
Located in the heart of Zurich, MOVU stands out as a leading online moving platform. Since its launch in May 2014, it has successfully coordinated over 60,000 moving services. MOVU is committed to providing its clients with a stress-free moving experience, emphasizing transparency in the moving industry. Each month, 3,000 people compare for free moving and handover cleaning quotes on the platform. https://www.movu.ch
Board Member & Angel Investor
Mar 2014
InSphero provides superior biological relevance to in vitro testing with easy-to-use solutions for production, culture and assessment of more organotypic 3D cell culture models. Our patented 3D cell culture platforms and methods enable large-scale, reproducible production of a broad range of assay-ready 3D InSight™ Microtissues derived from liver, pancreas, and tumor tissues. These models help to identify promising drugs and toxic liabilities with greater predictivity at early development stages, enabling better pre-clinical decision making, saving development cost, and shortening time to market. Microtissues are available directly or through a menu of 3D InSight™ Standard Services, supported by a comprehensive panel of 3D-optimized culture media, assay protocols, and imaging solutions. InSphero’s technologies drive significant findings in peer-reviewed journals, through collaborative projects such as EU Body on a Chip and HTS-DILI, and validation in the world’s largest government institutions and pharmaceutical, chemical and cosmetics companies. This 3D know-how is being applied in the diagnostics field to aid development of personalized chemotherapeutic strategies for the treatment of cancer. Founded in 2009 and privately held, InSphero is headquartered in Schlieren, Switzerland with subsidiaries in the United States (Brunswick, ME) and Waldshut, Germany. It has been recognized for its scientific and commercial achievements with a number of national and international awards.
Board Member & Angel Investor
Dec 2013
Since its founding in Zurich in 2009, Coople has developed into Europes largest digital platform for staff leasing with over 1 million registered employees and 30,000 companies. We place flexible workers for short- and long-term assignments in the areas of healthcare, gastronomy, hotel business, retail, aviation, logistics, events and promotion as well as in the commercial sector.
Angel Investor
Dec 2011
Climeworks empowers people and companies to fight global warming by offering carbon dioxide removal as a service via Direct Air Capture (DAC) technology. At Orca and Mammoth, Climeworks’ DAC facilities in Iceland, the CO₂ is permanently removed from the air by capturing and geologically storing it for thousands of years with Climeworks’ storage partner Carbfix. Climeworks’ DAC facilities run exclusively on low carbon energy, and our modular CO₂ collectors can be stacked to build machines of any capacity. Founded by engineers Christoph Gebald and Jan Wurzbacher in 2009, Climeworks is on a journey to climate impact at scale. To do so, we strive to inspire 1 billion people to act and remove CO₂ from the air.
Angel Investor
Dec 2011
Imina Technologies develops, manufactures and distributes Swiss made high precision positioning instruments for optical and electron microscopes (SEM). Our flagship product is the miBot™, the world's most compact and versatile piezo-based robot. It is operated by scientist, lab managers and skilled professionals from various industries to intuitively interact with and characterize specimens at micro and nanoscale. Our most recent turnkey solutions enable semiconductor industry leaders to perform testing and failure analysis of microelectronic devices with more flexible and efficient workflows. Interested in joining us? Have a look at http://imina.ch/company/jobs
Angel Investor
Nov 2009
HouseTrip is an award-winning start-up making hotels a thing of the past. Founded by CEO Arnaud Bertrand and CFO Junjun Chen, HouseTrip.com went live in January 2010. We're now one of the world's largest holiday rental booking sites, in 2012 voted the #2 start-up in all of London, and are growing all the time. For the price of a tiny, soulless hotel room, our Guests are discovering that instead they can have an entire house, or apartment, or castle, or boat... We have over 300,000 quality properties in thousands of destinations around the globe - many with unbiased reviews from previous Guests - and our list is growing every day. When you stay in somebody's home, you get to experience the authentic reality of their neighbourhood, their city and their country. Your holiday with HouseTrip means getting to live like a local; relishing local restaurants, taking in resident sights and sounds and enjoying all the bits of your chosen destination that most visitors don't ever learn about. Shop for produce at the markets and then prepare a feast in your very own kitchen, or even put on a load of washing. Renting with HouseTrip is safe, because Guests use their debit/credit card to pay online with our secure system - no more risky money transfers. Plus, we hold back on paying the Host until two days after you've checked in for added security. HouseTrip has offices in the UK (London), Portugal (Lisbon) and Switzerland (Lausanne).
Angel Investor
Dec 2007
IMMOMIG SA was founded by Patrick Maillard in 2004 while he was studying computer science at the University of Fribourg. It is one of Switzerland’s leading providers of real estate software, with more than 6,000 users as of 1 January 2021. Patrick Maillard won the Venture Leaders award in 2007. Five years later, IMMOMIG SA became a supporting member of the Swiss Chamber of Real Estate Agents (SCREA) and SVIT Romandie. Patrick Maillard (founder and CEO) and Etienne Kneuss (CTO and partner) are supported by a team of 40 people. The team consists of property market experts, developers and sales, customer support and customer service specialists, as well as multimedia design and marketing experts. A complete solution IMMOMIG SA develops and markets a complete solution for real estate agents, managers, architects, property developers and construction businesses. The Immomig® concept includes: • User-friendly online real estate software at the cutting edge of technology. • A modern website for your agency and promotions. • A mobile app available for iPhone and Android. • A free property portal: immomig-portal.ch. • A premium service for support and sales. Comprehensive software Immomig® helps users to quickly and easily manage their properties, contacts, publications and website. It also includes a number of modules: ‘new property project management’, ‘mortgage financing’, ‘automatic response to customer requests’, … The other innovative tools include Immomig® MLS (create your network and collaborate with partner agencies to sell properties), Global Matching (automatically match your customers with your properties) and automatic distance calculation.
Board Member & Angel Investor
Jun 2001
JobCloud is the leading digital company in the Swiss job market and offers various recruitment solutions. In addition to the leading job portals such as jobs.ch, JobScout24.ch and jobup.ch, the portfolio also includes JobCloud HR Tech, where promising technologies for recruitment are developed and offered, and JobCloud HR Services. JobCloud was founded in 2013 and is owned by Ringier and TX Group. More than 300 employees from 25 nations work for JobCloud in Zurich, Geneva, Vienna, Belgrade and Cluj. Our culture is based on the values One Team, Passion, Customer Centricity, Diversity&Inclusion and Performance. By the way, these were defined by our employees themselves.
Show all 16 investments ↓
Experience · 20 entries
All (20)
Investments (17)
Founder (2)
Board (6)
2019
Board Member & Angel Investor
Dec 2019
Exeon is a leading Swiss cyber security company, dedicated to protecting enterprise IT environments through AI-driven security analytics. The award-winning algorithms behind our flagship product ExeonTrace are based on over ten years of academic research at ETH Zürich and have been proven, expanded, and refined in global enterprise protection ever since. Exeon was awarded as one of Switzerland’s top three high-tech companies and consists of an interdisciplinary team of data scientists, machine learning experts, white hat hackers, network security specialists and business professionals. Our future-proof Network Detection and Response (NDR) software ExeonTrace allows security teams to monitor all network operations, immediately detect cyberthreats, and effectively secure their digital assets. As ExeonTrace relies on Metadata Analysis, its algorithms require no hardware sensors, are unaffected by encryption, and can be setup within a single day.
Board Member & Angel Investor
Feb 2019
greenteg provides high precision sensors for thermal sensing. Our sensors are integrated into OEM products and applied in R&D settings. All our products are fully developed and manufactured in Switzerland. 👉 Contact us to discuss your application at info@greenteg.com greenTEG AG was founded in 2009 as a spin-off of the Swiss Federal Institute of Technology (ETH). The company develops, manufactures, and markets thermal sensors for heat flux measurements in various applications and provides consulting on the thermal integration of its products. Today, greenTEG supplies OEMs as well as scientists in corporate and university labs around the world with its unique products. In 2020 greenTEG has launched CORE, the first wearable to measure continuously and non-invasively your core body temperature, clinical grade-wise. To discover more: 👉 www.greenTEG.com
2018
Angel Investor
Oct 2018
1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention and management of disease and empowers people to live better lives. 1DROP highly values collaboration, prioritizing the needs of customers and rapidly delivering solutions. 1DROP’s innovative diagnostic solutions for multiplexed assays of proteins, nucleic acids and peptides serve as tools for the development of new therapies and drugs, disease research, and clinical diagnostic tests. The company is based in Neuchatel, Switzerland and Boston, United States and is supported by some of the most highly regarded experts in the field of biosensors.
Board Member & Angel Investor
Jun 2018
Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems’ main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise.
2017
Angel Investor
Jul 2017
Synple Chem is changing the way in which chemical synthesis is done by providing a new automated synthesis technology that uses revolutionary, smart reagent capsules to make the synthesis of molecules faster and more efficient. Using this technology researchers in chemistry are able to accelerate their research and advance their programs in a fraction of the time. Our product addresses many of the limitations of chemical synthesis by enabling researchers with even basic chemistry expertise to rapidly synthesize organic compounds, in a fully automated manner that obviates the need to weigh and measure all but one of the reaction components; avoiding the use of excess reagents; eliminating tedious reaction workups; and ultimately freeing up the user to do more, faster!
Show all 20 entries ↓
Investment activity
2001–2019 · 17 investments
200122006120071200912011220131201422015120161201712018220192
Recent (last 2 years)Earlier